| 5156 |
Centers for Disease Control and Prevention |
Html |
en |
Michigan Activities to Prevent HAIs |
null |
| monthly update | 0.776068 |
| list Skip | 0.761939 |
| Infection Prevention | 0.466892 |
| infectious disease | 0.777544 |
|
| page options Skip | 0.955402 |
| email address | 0.701019 |
| Infection Control Assessment | 0.731638 |
| navigation Skip | 0.772889 |
|
CLICK HERE |
| 5343 |
Centers for Disease Control and Prevention |
Html |
en |
Frequently Asked Questions - Lyme Disease |
Information on Lyme disease. Provided by the U.S. Centers for Disease Control and Prevention. |
| post Lyme disease | 0.428008 |
| Lyme disease spirochete | 0.481748 |
| disease reporting | 0.332966 |
| health care provider | 0.346556 |
| Lyme disease education | 0.432215 |
| Lyme disease syndrome | 0.432015 |
| Lyme disease bull | 0.440768 |
| Disease Control | 0.333972 |
| transmit Lyme disease | 0.444289 |
| Lyme disease detect | 0.432233 |
| No. Lyme disease | 0.444406 |
| health care providers | 0.338949 |
| Lone star ticks | 0.33307 |
| southern Lyme disease | 0.443305 |
| Borrelia burgdorferi | 0.43919 |
| Lyme disease cases | 0.433694 |
| post-treatment Lyme disease | 0.428133 |
| lone star tick | 0.332826 |
| Clinician-Diagnosed Lyme Disease | 0.425826 |
| Lyme disease patients | 0.439208 |
| Lyme disease transmission | 0.437058 |
| Western Blot test | 0.364234 |
| bacterium Borrelia burgdorferi | 0.331756 |
| surveillance case definition | 0.331797 |
| disease manual increases | 0.34229 |
|
| Lyme disease bacterium | 0.432842 |
| Lyme Corps members | 0.402374 |
| Lyme disease symptoms | 0.440275 |
| blacklegged ticks | 0.369934 |
| Lyme disease surveillance | 0.424975 |
| Lyme Disease Testing | 0.426524 |
| Lyme Corps | 0.415085 |
| tick bite sites | 0.33487 |
| lyme disease | 0.995088 |
| tickborne diseases | 0.341403 |
| Lyme disease bacteria | 0.468759 |
| public health | 0.36034 |
| health care | 0.35429 |
| early lyme disease | 0.4483 |
| chronic lyme disease | 0.466784 |
| Lyme endemic areas | 0.406653 |
| Untreated Lyme disease | 0.438573 |
| Lyme Disease–United States | 0.404471 |
| Lyme Corps participants | 0.40266 |
| disease endemic areas | 0.345086 |
| tick bite | 0.34958 |
| infectious disease specialists | 0.342836 |
| lone star | 0.344702 |
| Lyme disease prevention | 0.42328 |
|
CLICK HERE |
| 5750 |
Centers for Disease Control and Prevention |
Html |
en |
Particulates not otherwise regulated - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7908 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Nigeria - HIV/AIDS |
null |
| Ministry | 0.229992 |
| national HIV program | 0.72646 |
| national reference lab | 0.497964 |
| non-infectious diseases | 0.376326 |
| AIDS Relief | 0.38677 |
| HIV treatment services | 0.906783 |
| workforce development | 0.370422 |
| hiv/aids activities | 0.475582 |
| children | 0.227863 |
| Strategic Plan | 0.355084 |
| Emergency Plan | 0.395785 |
| rapid scale-up | 0.425496 |
| lives | 0.22793 |
| pace | 0.228185 |
| field evaluation | 0.356095 |
| CDC Nigeria office | 0.769826 |
| CDC’s HIV/AIDS | 0.494375 |
| quality | 0.226725 |
| Working | 0.226856 |
| corrections | 0.227097 |
| Nigeria Web site | 0.54841 |
| support | 0.259418 |
| women | 0.227886 |
| laboratory capacity building | 0.51744 |
| country capacity | 0.378077 |
|
| key activities | 0.375983 |
| laboratory services | 0.381171 |
| National Medical Laboratory | 0.49771 |
| U.S. President | 0.38615 |
| robust combination prevention | 0.536998 |
| program performance | 0.370433 |
| epidemiology | 0.228036 |
| health information systems | 0.517673 |
| service delivery | 0.366529 |
| technical assistance | 0.391861 |
| operational research | 0.36092 |
| TB/HIV | 0.258168 |
| unique characteristics | 0.374274 |
| local epidemic help | 0.561982 |
| mother-to-child transmission | 0.3641 |
| program monitoring | 0.370862 |
| MOH | 0.340519 |
| maximum health impact | 0.537164 |
| Visit CDC | 0.475229 |
| PEPFAR | 0.230134 |
| TB | 0.235655 |
| HIV rapid test | 0.614801 |
| HIV prevention interventions | 0.668597 |
| data-driven approach | 0.390765 |
|
CLICK HERE |
| 7967 |
Centers for Disease Control and Prevention |
Html |
en |
Cell-based Flu Vaccines |
Overview of cell-based flu vaccines - CDC |
| vaccine manufacturing process | 0.567013 |
| cell-based vaccine manufacturing | 0.588437 |
| cell-based candidate vaccine | 0.885804 |
| cell-based flu vaccine | 0.881416 |
| cell-based flu vaccines | 0.671326 |
| injectable influenza vaccines | 0.350965 |
| FDA’s approval | 0.270492 |
| egg-adapted changes | 0.346465 |
| significant difference | 0.255452 |
| egg-isolated candidate vaccine | 0.413392 |
| major advantage | 0.251344 |
| egg-manufactured flu vaccines | 0.404944 |
| traditional technology | 0.256916 |
| U.S. Food | 0.264384 |
| injection site | 0.251262 |
| different manufacturing process | 0.310607 |
| U.S.-licensed vaccines | 0.296741 |
| cell-isolated candidate vaccine | 0.411685 |
| egg-based manufacturing process | 0.490234 |
| specific flu viruses | 0.421418 |
| animal cells | 0.312405 |
| Cell banking | 0.253167 |
| FDA approval | 0.271105 |
| cell-grown CVVs | 0.255636 |
|
| egg-based flu vaccines | 0.495481 |
| influenza virus | 0.267932 |
| manufacturing process | 0.596353 |
| adequate supply | 0.309096 |
| FDA | 0.339932 |
| United States | 0.255087 |
| Flucelvax cell-based vaccine | 0.507868 |
| vaccine production | 0.340468 |
| multiple European countries | 0.294741 |
| Drug Administration | 0.264355 |
| Madin-Darby Canine Kidney | 0.299479 |
| licensed cell-based flu | 0.474899 |
| traditional egg-based manufacturing | 0.391913 |
| chicken eggs | 0.257511 |
| immune response | 0.253913 |
| important implications | 0.253401 |
| liquid culture | 0.254746 |
| cultured cells | 0.261877 |
| candidate vaccine viruses | 0.997591 |
| cell culture technology | 0.571329 |
| wild-type circulating viruses | 0.353185 |
| influenza viruses | 0.416343 |
| production processes | 0.25879 |
| mammalian origin | 0.255893 |
|
CLICK HERE |
| 9674 |
Centers for Disease Control and Prevention |
Html |
en |
Other Asbestos Resources - NIOSH Workplace Safety and Health Topics |
null |
| United Air Toxics | 0.677734 |
| list Skip | 0.784694 |
| Asbestos | 0.43189 |
| John P. Peeters | 0.685832 |
| page options Skip | 0.921124 |
| National Research Council | 0.673281 |
| Mortimer L. Mendelsohn | 0.713494 |
| Committee | 0.423064 |
| Environmental Health Hazards | 0.689425 |
| Lawrence C. Mohr | 0.68318 |
| navigation Skip | 0.788124 |
|
| Asbestiform Fibers | 0.680314 |
| Joseph Henry Press | 0.647563 |
| Washington DC | 0.659014 |
| Toxicology | 0.436927 |
| ISBN | 0.490353 |
| Eds | 0.441802 |
| Academy Press | 0.544741 |
| EPA | 0.431801 |
| Biomarkers | 0.45151 |
| Nonoccupational Health Risks | 0.94966 |
|
CLICK HERE |
| 11383 |
Centers for Disease Control and Prevention |
Html |
en |
What's special about Chemical, Biological, Radiological, and Nuclear (CBRN) powered air-purifying respirators (PAPR)? (2013-156) |
null |
| respiratory protection program | 0.946535 |
| list Skip | 0.663084 |
| page options Skip | 0.857328 |
| special features | 0.414829 |
| NIOSH-approved chemical | 0.405278 |
| protection program administrators | 0.591261 |
| personal protection | 0.388638 |
| navigation Skip | 0.668164 |
| protection program administrator | 0.559257 |
|
| respirators | 0.267562 |
| air-purifying respirator | 0.514057 |
| NIOSH-approved industrial PAPR | 0.555366 |
| PAPR manufacturer recommendations | 0.556015 |
| storage requirements | 0.404332 |
| PAPR wearers | 0.475373 |
| managers | 0.266591 |
| unique performance | 0.40586 |
|
CLICK HERE |
| 13793 |
Centers for Disease Control and Prevention |
Html |
en |
Announcement: Recommendation Regarding CardiovascularDisease Prevention and Control from the Community PreventiveServices Task Force |
The Community Preventive Services Task Force recently posted new information about two recommendations: 1) "Self-Measured Blood Pressure Monitoring Interventions for Improved Blood Pressure Control — When Used Alone," available at http://www.thecommunityguide.org/cvd/SMBP-alone. |
| Pressure Monitoring Interventions | 0.867744 |
| Blood Pressure Control | 0.834379 |
| prevention experts | 0.405295 |
| CDC | 0.459837 |
| endorsement | 0.301445 |
| Human Services | 0.737553 |
| recommendations | 0.263565 |
| research | 0.230722 |
| U.S. Department | 0.745911 |
| MMWR HTML versions | 0.52748 |
| task force | 0.986738 |
| identification | 0.230142 |
| electronic PDF version | 0.51274 |
| review | 0.230505 |
| new information | 0.410414 |
| members | 0.233204 |
| Preventive | 0.235234 |
| population health | 0.398205 |
| Contact GPO | 0.417286 |
| Director | 0.233153 |
| commercial sources | 0.386426 |
| decision makers | 0.386327 |
| current prices | 0.372925 |
| original paper copy | 0.507487 |
|
| Improved Blood Pressure | 0.844819 |
| programs | 0.260032 |
| Self-Measured Blood Pressure | 0.835702 |
| Additional Support | 0.407553 |
| wide range | 0.392512 |
| Blood Pressure Monitoring | 0.835513 |
| U.S. Government Printing | 0.515157 |
| policies | 0.23106 |
| Superintendent | 0.234749 |
| MMWR readers | 0.390029 |
| character translation | 0.373612 |
| technical support | 0.388265 |
| MMWR paper copy | 0.519156 |
| public health | 0.419105 |
| format errors | 0.378666 |
| approval | 0.232666 |
| typeset documents | 0.385838 |
| trade names | 0.386599 |
| Services Task Force | 0.691346 |
| official text | 0.370629 |
| non-CDC sites | 0.382439 |
| uncompensated panel | 0.398509 |
| electronic conversions | 0.372077 |
| printable versions | 0.365944 |
|
CLICK HERE |
| 14021 |
Centers for Disease Control and Prevention |
Html |
null |
Global Cancer Statistics |
Cancer statistics for worldwide and for low- and middle-income countries. |
|
|
CLICK HERE |
| 14500 |
Centers for Disease Control and Prevention |
Html |
en |
Radiation in Medicine: Medical Imaging Procedures | CDC Features |
Medical imaging tests are non-invasive procedures that allow doctors to diagnose diseases and injuries without being intrusive. Some of these tests involve exposure to ionizing radiation, which can present risks to patients. However, if patients understand the benefits and risks, they can make the best decisions about choosing a particular medical imaging procedure. |
| imaging examinations | 0.461569 |
| radiation experts | 0.498286 |
| small risks | 0.46782 |
| body | 0.463399 |
| Guide medical procedures | 0.515988 |
| protective lead shielding | 0.484116 |
| best treatment options | 0.493659 |
| medical condition | 0.464085 |
| medical imaging procedures | 0.81249 |
| Image Gently Alliance | 0.480376 |
| U.S. Food | 0.45071 |
| medical imaging procedure | 0.633074 |
| health concern | 0.450296 |
| chest x-rays | 0.480888 |
| Image Wisely website | 0.481241 |
| x-ray procedure | 0.451273 |
| doctors | 0.454699 |
| large acute exposure | 0.495685 |
| particular medical imaging | 0.545069 |
| good treatment option | 0.488456 |
| medical tests | 0.481103 |
| Pediatric Imaging | 0.461006 |
| potential risks | 0.465221 |
| Drug Administration | 0.450691 |
| x-rays | 0.505656 |
|
| lowest exposure | 0.452134 |
| radiation safety | 0.491238 |
| monitor health conditions | 0.497676 |
| appropriate imaging techniques | 0.502248 |
| dental x-rays | 0.48158 |
| diagnostic ionizing radiation | 0.570349 |
| medical needs | 0.462443 |
| best decisions | 0.453358 |
| medical imaging tests | 0.772422 |
| alternative imaging methods | 0.503314 |
| adult medical imaging | 0.517178 |
| good quality image | 0.485693 |
| non-invasive procedures | 0.463918 |
| common examples | 0.451472 |
| background information | 0.450631 |
| spine x-rays | 0.480286 |
| doctor | 0.471854 |
| risks | 0.519766 |
| medical benefit | 0.457327 |
| body structures | 0.450193 |
| radiation | 0.6195 |
| joint replacement options | 0.487555 |
| good clinical image | 0.480263 |
| information | 0.461475 |
|
CLICK HERE |